Cargando…
Study protocol on the role of intestinal microbiota in colorectal cancer treatment: a pathway to personalized medicine 2.0
PURPOSE: Investigate in patients with metastatic and/or irresectable colorectal cancer treated with systemic treatment with capecitabine or TAS-102 whether: 1. Intestinal microbiota composition can act as a predictor for response. 2. Intestinal microbiota composition changes during systemic treatmen...
Autores principales: | Aarnoutse, R., de Vos-Geelen, J. M. P. G. M., Penders, J., Boerma, E. G., Warmerdam, F. A. R. M., Goorts, B., Olde Damink, S. W. M., Soons, Z., Rensen, S. S. M., Smidt, M. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486633/ https://www.ncbi.nlm.nih.gov/pubmed/28444508 http://dx.doi.org/10.1007/s00384-017-2819-3 |
Ejemplares similares
-
The Clinical Link between Human Intestinal Microbiota and Systemic Cancer Therapy
por: Aarnoutse, Romy, et al.
Publicado: (2019) -
Gut microbiota and short‐chain fatty acid alterations in cachectic cancer patients
por: Ubachs, Jorne, et al.
Publicado: (2021) -
Intestinal Microbiota in Postmenopausal Breast Cancer Patients and Controls
por: Aarnoutse, Romy, et al.
Publicado: (2021) -
Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
por: Aarnoutse, Romy, et al.
Publicado: (2022) -
Bile acids drive the newborn’s gut microbiota maturation
por: van Best, N., et al.
Publicado: (2020)